Published: October 2023
Roots Analysis has announced the addition of “Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, 2023-2035” report to its list of offerings.
Traditional primary packing is fraught with several challenges, including delayed production timelines and stringent regulations. This has prompted the industry stakeholders to shift their focus towards pre-sterilized / ready to use (RTU) primary packaging solutions. These ensure product quality, meet regulatory requirements, and streamline manufacturing processes.
To order this 350+ pages report, which features 155+ figures and 185+ tables, please visit link
Close to 45% of the pre-sterilized / ready to use containers are vials; majority (85%) of these are available in the nest and tub packaging format. Further, majority of the pre-sterilized / RTU containers are made of borosilicate glass.
Around 60% of the pre-sterilized / ready to use closures are stoppers; majority (65%) of these are compatible with vials. It is worth noting that around 85% of the pre-sterilized / RTU closures are sterilized using gamma irradiation.
Mergers and acquisitions emerged as the most common type of partnership model adopted by the stakeholders engaged in this industry, during the period 2015-2023. Further, majority of the intercontinental and intracontinental deals have been inked by players based in Europe.
Within the report, we have proposed a comprehensive framework that empowers stakeholders to make well-informed decisions regarding entry into RTU industry. This strategic framework takes into consideration multiple parameters, such as product reach, product competitiveness, manufacturing complexity, market activity, and product differentiation.
It is worth highlighting that the demand for pre-sterilized / ready to use sterile vials is anticipated to grow at a CAGR of ~10% during the forecast period. Further, 45% of the current demand is likely to be generated from RTU Syringes
In terms of type of container, the market is expected to be driven by sales of sterile vials, till 2035. In addition, in the long term, majority of the market share is anticipated to be captured by plastic containers and closures (46%), followed by glass containers and closures (39%).
To request a sample copy / brochure of this report, please visit link
The financial opportunity within the pre-sterilized / ready to use pharmaceutical packaging market has been analysed across the following segments:
The report features inputs from eminent industry stakeholders, according to whom, the rising demand for sterile vials and sterile syringes will provide lucrative opportunities for RTU manufacturers. The report includes detailed transcripts of the discussions held with following industry experts:
The research also includes profiles of key players (listed below) engaged in the pre-sterilized / ready to use pharmaceutical packaging market; each profile features an overview of the company, details related to its financial information (if available), product portfolio, recent developments, and an informed future outlook.
For additional details, please visit https://www.rootsanalysis.com/reports/pre-sterilized-ready-to-use-primary-packaging-market/224.html or email email@example.com
+1 (415) 800 3415
+44 (122) 391 1091
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry
SUBSCRIBE TO INDUSTRY UPDATES